Exclusive: Activist investor Elliott has taken position in Germany's Bayer – sources

0
© Reuters. FILE PHOTO: The logo of Bayer AG is pictured at the Bayer Healthcare subgroup production plant in Wuppertal© Reuters. FILE PHOTO: The logo of Bayer AG is pictured at the Bayer Healthcare subgroup production plant in Wuppertal

By Arno Schuetze and Greg Roumeliotis

FRANKFURT/NEW YORK (Reuters) – Activist investor Elliott has taken a position in Germany’s Bayer (DE:), the latest in a string of investments in German companies, three people familiar with the matter told Reuters on Friday.

Elliott has held shares in Bayer already for more than one year, two of the sources said, declining to specify the size of the stake.

The activist fund, owned by Paul Singer, declined to comment. Bayer did not have an immediate comment.

While Elliott has tried to talk to Bayer’s top management, it has not been able to get a meeting with Bayer Chief Executive Werner Baumann or one of his colleagues, one of the sources said.

Elliott owns stakes in German steelmaker ThyssenKrupp (DE:), utility Uniper (DE:) and food processing machinery maker GEA Group (DE:). It has pushed for strategy changes at those companies.

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.